<DOC>
	<DOCNO>NCT02871258</DOCNO>
	<brief_summary>To study objective evaluate impact use The MetaNeb® System clearance atelectasis , demonstrate improvement chest x-ray . This non-randomized open label study , subject receive treatment The MetaNeb® System . Subjects qualify enrollment study receive therapy The MetaNeb® System follow labeled instruction device . Details treatment include duration frequency define treatment procedure .</brief_summary>
	<brief_title>MetaNeb® Chest X-ray Study</brief_title>
	<detailed_description>Study Population : Post-surgical ( thoracic , cardiac abdominal surgery ) non-mechanically ventilated patient significant atelectasis document chest x-ray result . Duration treatment : Duration treatment The MetaNeb® System minimum 48 hour , subject discharge hospital ( discharge early ) . Enrolled subject remain study Day 4 subject discharge hospital , whichever occur sooner .</detailed_description>
	<mesh_term>Pulmonary Atelectasis</mesh_term>
	<criteria>Postsurgical ( thoracic , cardiac abdominal surgery ) Age ≥ 18 year Significant atelectasis chest xray Patient meet indication therapy intervention define Recruitment Airway Clearance Protocol ( Respiratory Department Policy Procedure ) Signed informed consent Cause atelectasis suspect infectious solid mass Requirement mechanical ventilation Requirement chronic supplemental oxygen Hemodynamically unstable , define need vasopressor therapy Anticipated need mechanical ventilation poor clinical outcome , unrelated atelectasis secretion retention Contraindication MetaNeb® therapy ( untreated tension pneumothorax ) Inability perform MetaNeb® therapy use mouthpiece Anticipated hospital discharge within 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>